CAR-T cells therapy (The first affiliated hospital of medical college of zhejiang university)

N/A

Report date: 2025/11/25 20:00:09

Base Information

Drug NameCAR-T cells therapy (The first affiliated hospital of medical college of zhejiang university)
Drug Alias NameChimeric antigen receptor T cells therapy(The first affiliated hospital of medical college of zhejiang university)CT0991CT-0991
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionT lymphocyte replacements
TargetsUpdating
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaPending
Originator CompaniesThe First Affiliated Hospital Of Zhejiang University School Of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe First Affiliated Hospital Of Zhejiang University School Of Medicine
Active IndicationsN/A
Inactive IndicationsLeukemia, Myeloid, Acute

Other Information

ATC CodeN/A
Related LinksN/A